ORIGINAL RESEARCH article

Front. Public Health

Sec. Aging and Public Health

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1584386

Temporal trends in dementias in older adults attributable to high fasting plasma glucose from 1990 to 2021 and forecasted disease burden in 2040 in China and globally

Provisionally accepted
Pinyuan  DaiPinyuan Dai1Jie  YuJie Yu2Yongxing  LinYongxing Lin1Xiaoyan  ZhouXiaoyan Zhou1Hao  WangHao Wang1Weiwei  GongWeiwei Gong1Jin  PanJin Pan1Yunqi  GuanYunqi Guan1Jieming  ZhongJieming Zhong1Na  LiNa Li1*Zuyun  LiuZuyun Liu2*
  • 1Zhejiang Center for Disease Control and Prevention (Zhejiang CDC), Hangzhou, China
  • 2Zhejiang University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

The Global Burden of Diseases Study systematically updates the dementia burden attributable to high fasting plasma glucose (HFPG) to investigate the temporal trends of dementia burden and promote comparisons between countries, sexes, and age groups. In this study, we aimed to estimate the disease burden of dementia attributable to HFPG using an age-period-cohort model in adults aged >60 years from 1990 to 2021 and forecast the mortality and disability-adjusted life-years (DALYs) rates in China and globally in 2040. Method: Data on the mortality and DALYs rates of dementia attributable to HFPG in China and globally were extracted from the Global Burden of Disease Study 2021. An age-period-cohort model was used to estimate the net drift, local drift, fitted longitudinal age-specific rates, and period/cohort relative risks from 1990 to 2021. The Bayesian ageperiod-cohort model was used to predict future mortality and DALYs rates from 2022 to 2040. Results: The net drifts showed an overall upward trend in the dementia burden attributable to HFPG in China and globally from 1990 to 2021, with a much slower trend in China. A constantly rising risk for age and birth cohort effects was observed, while period effects presented a globally constantly increasing risk and two inflection points in China, probably due to healthcare reform. The forecasted disease burden by 2040 demonstrated an increasing trend globally and a declining trend in China.The burden of dementia attributable to HFPG has consistently increased globally over the past 30 years but has gradually declined in China in recent years. China's strategies for preventing and managing diabetes and dementia may provide valuable insights for other regions. Further targeted policies are required to reduce the burden on females and older adults, particularly to improve their quality of life.

Keywords: Global burden of disease, Dementia, Risk factors, Glucose, diabetes, China

Received: 27 Feb 2025; Accepted: 31 May 2025.

Copyright: © 2025 Dai, Yu, Lin, Zhou, Wang, Gong, Pan, Guan, Zhong, Li and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Na Li, Zhejiang Center for Disease Control and Prevention (Zhejiang CDC), Hangzhou, China
Zuyun Liu, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.